H. Armendariz
Instituto Argentino de Diagnóstico y Tratamiento(AR)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Hematopoietic Stem Cell Transplantation, Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors
Most-Cited Works
- → Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group(2013)233 cited
- → Treatment strategy and long-term results in pediatric patients treated in two consecutive AML-GATLA trials(2005)17 cited
- → Childhood acute leukemia: A single institution experience in La Plata, Argentina(2001)13 cited
- → Addition of Liposomal Daunorubicin (DaunoXome®) to FLAG Significantly Improves Treatment Response in Pediatric Relapsed AML: Final Results From the International Randomised Phase III Study Relapsed AML 2001/01.(2009)7 cited
- → Low efficacy of methotrexate in childhood acute myeloid leukemia (AML): Single‐agent therapeutic window study in relapsed AML(2005)4 cited
- → Relapsed Acute Myeloid Leukemia in Children and Adolescents: Interim Results of the International Randomised Phase III Study “Relapsed AML 2001/01”.(2005)4 cited
- → Central Nervous System (CNS) Involvement In Pediatric Relapsed Acute Myeloid Leukemia: Results and Lessons From Study Relapsed AML 2001/01(2010)3 cited
- → Prognostic Significance of Early Treatment Response in Pediatric Relapsed Acute Myeloid Leukemia: Results from the International Study Relapsed AML 2001/01.(2007)2 cited
- → Methotrexate in Relapsed Childhood Acute Myeloid Leukemia: A Single Agent Therapeutic Window Study.(2004)1 cited
- → Prognostic Significance of Time to Relapse in Pediatric AML: Results from the International Randomised Phase III Study Relapsed AML 2001/01(2008)1 cited